DBV's peanut prevention patch approaches key stage of approval process

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 21, 2020 at 10:42 AM.

  1. #1 cafead, Feb 21, 2020 at 10:42 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Almost a year and a half after DBV Technologies pulled its peanut allergy immunotherapy patch from FDA review, the biotech will get their day in court. The FDA has scheduled an advisory committee hearing for May 15.

    article source
     
    Quote

Reply to Thread